drugset / Trial / NCT01292408

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

NCT01292408

Phase 2 Unknown 20 enrolled Radboud University Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Hydroxychloroquine is a drug that has been used to treat malaria and rheumatism. It is recently discovered that Hydroxychloroquine increases 'autophagy'. Autophagy is a process whereby cells eat a part themselves giving them extra energy. Cancer cells use autophagy to survive chemotherapy or hormonal therapy. Also, cancer cells use autophagy to survive in areas of a tumor where there is a low oxygen level. The purpose of this study is to determine whether treatment with the drug Hydroxychloroquine leads to a decrease of autophagy in breast cancer tissue.

Timeline

Start
2011-01
Primary completion
2012-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 400 mg Oral

Indications